Literature DB >> 28657137

A novel PAX1 null homozygous mutation in autosomal recessive otofaciocervical syndrome associated with severe combined immunodeficiency.

I Paganini1, R Sestini1, G L Capone1, A L Putignano1, E Contini2, I Giotti2, F Gensini1, A Marozza1,3, A Barilaro4, B Porfirio1, L Papi1.   

Abstract

Otofaciocervical syndrome (OFCS) is a rare disorder characterized by facial anomalies, cup-shaped low-set ears, preauricular fistulas, hearing loss, branchial defects, skeletal anomalies, and mild intellectual disability. Autosomal dominant cases are caused by deletions or point mutations of EYA1. A single family with an autosomal recessive form of OFCS and a homozygous missense mutation in PAX1 gene has been described. We report whole exome sequencing of 4 members of a consanguineous family in which 2 children, showing features of OFCS, expired from severe combined immunodeficiency (SCID). To date, the co-occurrence of OFCS and SCID has never been reported. We found a nonsense homozygous mutation in PAX1 gene in the 2 affected children. In mice, Pax1 is required for the formation of specific skeletal structures as well as for the development of a fully functional thymus. The mouse model strongly supports the hypothesis that PAX1 depletion in our patients caused thymus aplasia responsible for SCID. This report provides evidence that bi-allelic null PAX1 mutations may lead to a multi-system autosomal recessive disorders, where SCID might represent the main feature.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990PAX1; zzm321990SCID; zzm321990WES; consanguineous family; otofaciocervical syndrome; severe combined immunodeficiency

Mesh:

Substances:

Year:  2017        PMID: 28657137     DOI: 10.1111/cge.13085

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  17 in total

1.  FOXN1 compound heterozygous mutations cause selective thymic hypoplasia in humans.

Authors:  Qiumei Du; Larry K Huynh; Fatma Coskun; Erika Molina; Matthew A King; Prithvi Raj; Shaheen Khan; Igor Dozmorov; Christine M Seroogy; Christian A Wysocki; Grace T Padron; Tyler R Yates; M Louise Markert; M Teresa de la Morena; Nicolai Sc van Oers
Journal:  J Clin Invest       Date:  2019-11-01       Impact factor: 14.808

Review 2.  Thymus Functionality Needs More Than a Few TECs.

Authors:  Pratibha Bhalla; Dong-Ming Su; Nicolai S C van Oers
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

3.  Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Charlotte Cunningham-Rundles; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Eric Oksenhendler; Capucine Picard; Anne Puel; Jennifer Puck; Mikko R J Seppänen; Raz Somech; Helen C Su; Kathleen E Sullivan; Troy R Torgerson; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2022-06-24       Impact factor: 8.542

4.  PAX1 is essential for development and function of the human thymus.

Authors:  Yasuhiro Yamazaki; Raul Urrutia; Luis M Franco; Silvia Giliani; Kejian Zhang; Anas M Alazami; A Kerry Dobbs; Stefania Masneri; Avni Joshi; Francisco Otaizo-Carrasquero; Timothy G Myers; Sundar Ganesan; Maria Pia Bondioni; Mai Lan Ho; Catherine Marks; Huda Alajlan; Reem W Mohammed; Fanggeng Zou; C Alexander Valencia; Alexandra H Filipovich; Fabio Facchetti; Bertrand Boisson; Chiara Azzari; Bander K Al-Saud; Hamoud Al-Mousa; Jean Laurent Casanova; Roshini S Abraham; Luigi D Notarangelo
Journal:  Sci Immunol       Date:  2020-02-28

Review 5.  Congenital Athymia: Genetic Etiologies, Clinical Manifestations, Diagnosis, and Treatment.

Authors:  Cathleen Collins; Emily Sharpe; Abigail Silber; Sarah Kulke; Elena W Y Hsieh
Journal:  J Clin Immunol       Date:  2021-05-13       Impact factor: 8.317

6.  Care of Children with DiGeorge Before and After Cultured Thymus Tissue Implantation.

Authors:  Stephanie E Gupton; Elizabeth A McCarthy; M Louise Markert
Journal:  J Clin Immunol       Date:  2021-05-18       Impact factor: 8.542

Review 7.  Molecular Insights Into the Causes of Human Thymic Hypoplasia With Animal Models.

Authors:  Pratibha Bhalla; Christian A Wysocki; Nicolai S C van Oers
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

8.  Clinical, Immunological, and Molecular Features of Typical and Atypical Severe Combined Immunodeficiency: Report of the Italian Primary Immunodeficiency Network.

Authors:  Emilia Cirillo; Caterina Cancrini; Chiara Azzari; Silvana Martino; Baldassarre Martire; Andrea Pession; Alberto Tommasini; Samuele Naviglio; Andrea Finocchi; Rita Consolini; Paolo Pierani; Irene D'Alba; Maria Caterina Putti; Antonio Marzollo; Giuliana Giardino; Rosaria Prencipe; Federica Esposito; Fiorentino Grasso; Alessia Scarselli; Gigliola Di Matteo; Enrico Attardi; Silvia Ricci; Davide Montin; Fernando Specchia; Federica Barzaghi; Maria Pia Cicalese; Giuseppe Quaremba; Vassilios Lougaris; Silvia Giliani; Franco Locatelli; Paolo Rossi; Alessandro Aiuti; Raffaele Badolato; Alessandro Plebani; Claudio Pignata
Journal:  Front Immunol       Date:  2019-08-13       Impact factor: 7.561

Review 9.  The Ever-Increasing Array of Novel Inborn Errors of Immunity: an Interim Update by the IUIS Committee.

Authors:  Stuart G Tangye; Waleed Al-Herz; Aziz Bousfiha; Charlotte Cunningham-Rundles; Jose Luis Franco; Steven M Holland; Christoph Klein; Tomohiro Morio; Eric Oksenhendler; Capucine Picard; Anne Puel; Jennifer Puck; Mikko R J Seppänen; Raz Somech; Helen C Su; Kathleen E Sullivan; Troy R Torgerson; Isabelle Meyts
Journal:  J Clin Immunol       Date:  2021-02-18       Impact factor: 8.317

Review 10.  T-Cell Immunodeficiencies With Congenital Alterations of Thymic Development: Genes Implicated and Differential Immunological and Clinical Features.

Authors:  Giuliana Giardino; Carla Borzacchiello; Martina De Luca; Roberta Romano; Rosaria Prencipe; Emilia Cirillo; Claudio Pignata
Journal:  Front Immunol       Date:  2020-08-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.